用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Radiolabeled Monoclonal Antibodies for Imaging and Therapy; Suresh C. Srivastava Conference proceedings 1988 Springer Science+Business Med

[复制链接]
楼主: 根深蒂固
发表于 2025-3-23 10:28:06 | 显示全部楼层
Optimization of Mouse IgG Fragmentation Technique in the Selection of Monoclonal Antibodies for Myocse of myosin fragments. Three monoclonal antibodies selected for their high affinity for human ventricular myosin heavy chains (Leger et al., 1985) are chosen for their cross-reactivity (95%) with canine myosin.
发表于 2025-3-23 14:53:49 | 显示全部楼层
Sensitivity and Efficacy Indices for Oncologic Data Reporting reconcile data from various centers since they report tumor imaging results in a variety of different ways. The most commonly encountered problem is caused by differences in the method of data reporting. One center will describe sensitivity of detection by site of lesion, while another will report
发表于 2025-3-23 21:32:44 | 显示全部楼层
发表于 2025-3-23 22:13:03 | 显示全部楼层
发表于 2025-3-24 06:25:04 | 显示全部楼层
Experience with Iodine-123 Labeled Antibodiesfour factors is required: an antibody specific to the cancer in question; a radiolabel that is optimal for the imaging system and for the kinetics of antibody uptake; a method of labeling the antibody and quality control so that is is suitable for injection into the patient; and, a gamma camera imag
发表于 2025-3-24 09:42:31 | 显示全部楼层
发表于 2025-3-24 10:45:43 | 显示全部楼层
发表于 2025-3-24 16:39:13 | 显示全部楼层
Selection of Monoclonal Antibodies with Optimal Biological Functions for Clinical Applicationies conjugated with radioactive isotopes have been used extensively in preliminary investigations to localize tumor in cancer patients (3,4). In addition, there has been a great deal of current interest in the potential applications of these antibodies in the therapy of human cancer.
发表于 2025-3-24 19:36:08 | 显示全部楼层
Progress in Diagnostic Immunoscintigraphy and First Approach to Radioimmunotherapy of Colon Carcinom however, were performed with poorly characterized antibodies obtained by absorption and elution from tumor cells or crude tumor fractions. Thus, this type of antibodies could not be used for clinical applications.
发表于 2025-3-25 00:58:06 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-25 21:28
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表